相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015-2019
Yu-Lin Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
Yiwei Zhu et al.
MSYSTEMS (2021)
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
Yanyan Hu et al.
MICROBIOLOGY SPECTRUM (2021)
Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation
Ivica Letunic et al.
NUCLEIC ACIDS RESEARCH (2021)
An IncP-2 plasmid sublineage associated with dissemination of bla (IMP-45) among carbapenem-resistant Pseudomonas aeruginosa
Xuefei Zhang et al.
EMERGING MICROBES & INFECTIONS (2021)
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study
Tanya Babich et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme
Dee Shortridge et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology
Ester del Barrio-Tofino et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa
Dandan Yin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
Maroya Spalding Walters et al.
EMERGING INFECTIOUS DISEASES (2019)
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
Pablo A. Fraile-Ribot et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
Sameer S. Kadri et al.
CLINICAL INFECTIOUS DISEASES (2018)
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15
Krystyna M. Kazmierczak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Current Status and Trends of Antibacterial Resistance in China
Fupin Hu et al.
CLINICAL INFECTIOUS DISEASES (2018)
Activity of imipenem/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015-2016
James A. Karlowsky et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
Krystyna M. Kazmierczak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms
Gabriel Torrens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome
Shea N. Gardner et al.
BIOINFORMATICS (2015)
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey
M. Mac Aogain et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies
Hui Li et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
Jie Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
